Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis

BACKGROUND: Treatment of relapsed or refractory primary CNS lymphoma (r/r PCNSL) is difficult, particularly in patients not eligible for high dose chemotherapy with autologous stem cell transplantation (HDC-ASCT). No standard treatment has been defined for these patients yet. METHODS: We retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, Sabine, Kowalski, Thomas, Nilius-Eliliwi, Verena, Schroers, Roland, Schlegel, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948364/
https://www.ncbi.nlm.nih.gov/pubmed/36814351
http://dx.doi.org/10.1186/s42466-023-00234-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948364/
https://www.ncbi.nlm.nih.gov/pubmed/36814351
http://dx.doi.org/10.1186/s42466-023-00234-y

Ejemplares similares